Cadmium, von Willebrand factor and vascular aging

Area of Science:

• Cardiovascular Science
• Environmental Health
• Molecular Biology

Background:

• Vascular aging contributes significantly to cardiovascular disease, characterized by thickened and stiffened blood vessels.
• Endothelial cell dysfunction, driven by oxidative stress and inflammation, underlies vascular aging.
• Elevated plasma levels of von Willebrand Factor (vWF), a glycoprotein involved in coagulation, are associated with aging and promote thrombosis and atherosclerosis.

Purpose of the Study:

• To review the molecular mechanisms linking vWF to vascular aging pathologies.
• To examine how cadmium (Cd) exposure influences vWF expression.
• To propose low-dose Cd as a risk factor for vascular aging via vWF elevation.

Main Methods:

• Literature review of molecular mechanisms.
• Analysis of studies on vWF in vascular aging.
• Examination of research on cadmium's effects on endothelial cells and vWF.

Main Results:

• Elevated vWF exacerbates vascular aging by promoting thrombosis, plaque formation, and smooth muscle cell proliferation.
• Low-dose cadmium exposure, while activating pro-survival pathways, enhances intima-media thickness and atherogenesis.
• Cadmium exposure increases endothelial vWF expression and secretion both in vivo and in vitro.

Conclusions:

• vWF plays a critical role in the pathologies associated with vascular aging.
• Cadmium exposure at low doses elevates vWF levels.
• Low-dose cadmium exposure is a potential risk factor for vascular aging, mediated by increased plasma vWF.